Intercept Pharmaceuticals Inc

General

Total Cases9

Active Cases--

Patents60

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

interceptpharma.com

intercept-pharmaceuticals

intercept-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
03/06/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Judgment)(mdb) (Entered: 03/06/2024)
03/06/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	CONSENT JUDGMENT. Signed by Judge Maryellen Noreika on 3/6/2024. *Civil Case Terminated* (dlw) (Entered: 03/06/2024)
03/06/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	PROPOSED CONSENT JUDGMENT by Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 03/06/2024)
03/01/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	REDACTED VERSION of 99 Letter by Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 03/01/2024)
02/26/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendant's Fifth Set of Requests for Production (No. 37) filed by Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 02/26/2024)
02/26/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	ORAL ORDER re 99 Letter - Having reviewed the parties' letter and Proposed Amended Scheduling Order, IT IS HEREBY ORDERED that Plaintiffs' proposed deadlines are adopted up to the Markman hearing. The Markman hearing shall be reset for 10/7/2024 at 2:00 p.m. Daubert motions must be filed on or before 1/6/2025 and shall be briefed in accordance with the Local Rules. The Court will not move the Pretrial Conference and Trial dates. The parties shall file an amended [Proposed] Order Amending Scheduling Order incorporating these dates and using this guidance. ORDERED by Judge Maryellen Noreika on 2/26/2024. (dlw) (Entered: 02/26/2024) ORAL ORDER re 99 Letter - Having reviewed the parties' letter and Proposed Amended Scheduling Order, IT IS HEREBY ORDERED that Plaintiffs' proposed deadlines are adopted up to the Markman hearing. The Markman hearing shall be reset for 10/7/2024 at 2:00 p.m. Daubert motions must be filed on or before 1/6/2025 and shall be briefed in accordance with the Local Rules. The Court will not move the Pretrial Conference and Trial dates. The parties shall file an amended [Proposed] Order Amending Scheduling Order incorporating these dates and using this guidance. ORDERED by Judge Maryellen Noreika on 2/26/2024. (dlw) (Entered: 02/26/2024)
02/23/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	[SEALED] Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding case schedule. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 02/23/2024)
02/21/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendant's First Set of Requests for Admission (Nos. 1-37) filed by Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 02/21/2024)
02/08/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendant's Fourth Set of Interrogatories (Nos. 14-16) filed by Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 02/08/2024)
01/30/24	Intercept Pharma Inc v. Zenara Pharma Pvt Ltd 1:22-CV-01215 ( D. DE )	Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AlfaSigma S.p.A. for Intercept Pharmaceuticals, Inc. filed by Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/30/2024)